
AbbVie makes another local multibillion-dollar buy with Cerevel acquisition
AbbVie Inc. is on a shopping spree for Boston-area biotechs. … […]
AbbVie Inc. is on a shopping spree for Boston-area biotechs. … […]
The strategy is part of the administration’s new draft plan for the state’s economic development, which also touches on the workforce as well as industries like life sciences and climatetech. … […]
WELLESLEY, Mass., Dec. 6, 2023 /PRNewswire/ — Sun Life U.S. has received the Equality 100 Award from Human Rights Campaign, given to companies achieving a 100% score on the Corporate Equality Index (CEI), a national benchmarking survey that assesses LGBTQ equality in the workplace. This… … […]
Gov. Maura Healey’s proposed economic development plan offers some clues about how she’d run a Life Sciences Initiative 3.0. … […]
Clinical investigators complete enrollment in the 177 patient, randomized, controlled study, STAND (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in subjects with Arterial Disease Below the Knee, NCT03477604). WILMINGTON, Mass., Dec. 6, 2023 /PRNewswire/ — Micro… … […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will webcast its upcoming virtual R&D Day event on the Investors section of the Company’s website, www.alnylam.com, on Wednesday, December 13, 2023 at 8:30 am ET. A replay will be available on the Alnylam… … […]
Jeremy Hunt October and November were critical months in shaping the future of the UK’s biopharma sector. After several years of macroeconomic challenges, the government unveiled a bundle of new drug pricing, regulatory and financial measures in the fourth quarter aimed at increasing the… … […]
Julie Kim didn’t start her career as a natural leader. Then a manager told her that if she aspired to leadership, she needed to step out of her comfort zone — speak up at meetings, make herself known. … […]
It’s the third nine-figure round the Boston-based startup has raised in as many years. … […]
A Flagship Pioneering-backed biotech behind one of the only new drugs in development for long Covid is closing its doors. … […]
Copyright © 2023 Biotech Networks, LLC